Attendees:
AATec Medical GmbH
AbbVie Ventures
ABIVAX
Alternative Assets Finance
Altrovia
Andera Partners SA
Angelini Ventures S.p.A.
Apollo Health Ventures
Argobio Studio
Asahi Kasei Europe GmbH
Astellas Pharma Europe Ltd.
Baker McKenzie
BioMedPartners AG
BioMedVC AG
Bioqube Ventures
BIOSTART Consulting GmbH
Biovision Ventures
CARTemis Therapeutics GmbH
CDR-Life AG
Chugai Venture Fund, LLC
Debiopharm International SA
Diamante Società Benefit Srl
Eight Bridges
Eleva GmbH
Eli Lilly and Company
Elpiscience Biopharmaceuticals Co. Ltd.
Evidenze
Evotec AG
Expert Systems, Inc.
F. Hoffmann-La Roche AG
F. Hoffmann-La Roche Ltd.
Fontaine Capital
Forbion
Genius Search GmbH & Co. KG
HBM Partners AG
HEPHAISTOS-Pharma
High-Tech Gründerfonds Management GmbH
Intercontinental Capital
IPF Partners
Italian Angels for Growth (IAG)
J.P. Morgan Private Bank (Suisse) SA
Kerna Ventures
KreaMedica Holdings Inc.
Ksilink
Kurma Partners
Lifespan Vision Ventures LLC
Lumanity
Merck KGaA, Darmstadt, Germany
Micreos Pharmaceuticals AG
MIG Capital
Nerai Bioscience AG
Novartis Pharma AG
Novo Holdings A/S
NRW.Venture
Nucleus Network Ltd
OxSonics
Peppermint VenturePartners GmbH
Peregrine Ventures
PharmNovo AB
Phialogics AG
Ropes & Gray LLP
RV Invest GmbH
Sappiens SAS
Secarna Pharmaceuticals GmbH & Co. KG
Servier Ventures
Sobi
Stifel
Swiss Biotech Association
Terra Quantum AG
UZH Life Sciences Fund, AG
Valor Management
Vi Partners AG
Viopas Venture Consulting GmbH
XGEN Venture SGR S.p.A
Last updated: August 7, 2026